Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Ecosystem functioning impacts of the invasive seaweed Sargassum muticum (Fucales, Phaeophyceae).

Journal of phycology

Vaz-Pinto F, Olabarria C, Arenas F.
PMID: 26988012
J Phycol. 2014 Feb;50(1):108-16. doi: 10.1111/jpy.12136. Epub 2013 Dec 11.

Ongoing changes in natural diversity due to anthropogenic activities can alter ecosystem functioning. Particular attention has been given to research on biodiversity loss and how those changes can affect the functioning of ecosystems, and, by extension, human welfare. Few...

Cite
Vaz-Pinto F, Olabarria C, Arenas F. Ecosystem functioning impacts of the invasive seaweed Sargassum muticum (Fucales, Phaeophyceae). J Phycol. 2013;50(1):108-16doi: 10.1111/jpy.12136.
Vaz-Pinto, F., Olabarria, C., & Arenas, F. (2014). Ecosystem functioning impacts of the invasive seaweed Sargassum muticum (Fucales, Phaeophyceae). Journal of phycology, 50(1), 108-16. https://doi.org/10.1111/jpy.12136
Vaz-Pinto, Fátima, et al. "Ecosystem functioning impacts of the invasive seaweed Sargassum muticum (Fucales, Phaeophyceae)." Journal of phycology vol. 50,1 (2014): 108-16. doi: https://doi.org/10.1111/jpy.12136
Vaz-Pinto F, Olabarria C, Arenas F. Ecosystem functioning impacts of the invasive seaweed Sargassum muticum (Fucales, Phaeophyceae). J Phycol. 2014 Feb;50(1):108-16. doi: 10.1111/jpy.12136. Epub 2013 Dec 11. PMID: 26988012.
Copy Download .nbib Format: NLM
Correction: Using remote sensing to detect whale strandings in remote areas: The case of sei whales mass mortality in Chilean Patagonia.

PloS one

Fretwell PT, Jackson JA, Ulloa Encina MJ, Häussermann V, Perez Alvarez MJ, Olavarría C, Gutstein CS.
PMID: 31697790
PLoS One. 2019 Nov 07;14(11):e0225209. doi: 10.1371/journal.pone.0225209. eCollection 2019.

[This corrects the article DOI: 10.1371/journal.pone.0222498.].

Cite
Fretwell PT, Jackson JA, Ulloa Encina MJ, et al. Correction: Using remote sensing to detect whale strandings in remote areas: The case of sei whales mass mortality in Chilean Patagonia. PLoS One. 2019;14(11):e0225209doi: 10.1371/journal.pone.0225209.
Fretwell, P. T., Jackson, J. A., Ulloa Encina, M. J., Häussermann, V., Perez Alvarez, M. J., Olavarría, C., & Gutstein, C. S. (2019). Correction: Using remote sensing to detect whale strandings in remote areas: The case of sei whales mass mortality in Chilean Patagonia. PloS one, 14(11), e0225209. https://doi.org/10.1371/journal.pone.0225209
Fretwell, Peter T, et al. "Correction: Using remote sensing to detect whale strandings in remote areas: The case of sei whales mass mortality in Chilean Patagonia." PloS one vol. 14,11 (2019): e0225209. doi: https://doi.org/10.1371/journal.pone.0225209
Fretwell PT, Jackson JA, Ulloa Encina MJ, Häussermann V, Perez Alvarez MJ, Olavarría C, Gutstein CS. Correction: Using remote sensing to detect whale strandings in remote areas: The case of sei whales mass mortality in Chilean Patagonia. PLoS One. 2019 Nov 07;14(11):e0225209. doi: 10.1371/journal.pone.0225209. eCollection 2019. PMID: 31697790; PMCID: PMC6837315.
Copy Download .nbib Format: NLM
Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.

Journal of cancer research and clinical oncology

Steegmann JL, Colomer D, Gómez-Casares MT, García-Gutiérrez V, Ortí G, Ramírez-Payer A, Olavarria E, Vall-Llovera F, Giraldo P, Conde E, Vallansot R, López-Lorenzo JL, Palomera L, Álvarez-Larrán A, Conesa V, Bautista G, Casas L, Giles F, Hochhaus A, Casado-Montero LF.
PMID: 29063181
J Cancer Res Clin Oncol. 2018 Jan;144(1):187-188. doi: 10.1007/s00432-017-2532-1.

Correction to: J Cancer Res Clin Oncol (2017) 143:2059-2066 DOI 10.1007/s00432-017-2445-z.

Cite
Steegmann JL, Colomer D, Gómez-Casares MT, et al. Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase. J Cancer Res Clin Oncol. 2018;144(1):187-188doi: 10.1007/s00432-017-2532-1.
Steegmann, J. L., Colomer, D., Gómez-Casares, M. T., García-Gutiérrez, V., Ortí, G., Ramírez-Payer, A., Olavarria, E., Vall-Llovera, F., Giraldo, P., Conde, E., Vallansot, R., López-Lorenzo, J. L., Palomera, L., Álvarez-Larrán, A., Conesa, V., Bautista, G., Casas, L., Giles, F., Hochhaus, A., & Casado-Montero, L. F. (2018). Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase. Journal of cancer research and clinical oncology, 144(1), 187-188. https://doi.org/10.1007/s00432-017-2532-1
Steegmann, Juan Luis, et al. "Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase." Journal of cancer research and clinical oncology vol. 144,1 (2018): 187-188. doi: https://doi.org/10.1007/s00432-017-2532-1
Steegmann JL, Colomer D, Gómez-Casares MT, García-Gutiérrez V, Ortí G, Ramírez-Payer A, Olavarria E, Vall-Llovera F, Giraldo P, Conde E, Vallansot R, López-Lorenzo JL, Palomera L, Álvarez-Larrán A, Conesa V, Bautista G, Casas L, Giles F, Hochhaus A, Casado-Montero LF. Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase. J Cancer Res Clin Oncol. 2018 Jan;144(1):187-188. doi: 10.1007/s00432-017-2532-1. PMID: 29063181; PMCID: PMC5756548.
Copy Download .nbib Format: NLM
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.

Bone marrow transplantation

Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P, Ganser A, Nagler A, Snowden JA, Robin M, Passweg J, Van Gorkom G, Wallet HL, Hoek J, Blok HJ, De Witte T, Kroeger N, Hayden P, Chalandon Y, Agha IY.
PMID: 34599284
Bone Marrow Transplant. 2021 Oct 01; doi: 10.1038/s41409-021-01472-x. Epub 2021 Oct 01.

Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibitors (TKIs). While imatinib seems to have no adverse impact on outcomes after transplant, little is...

Cite
Masouridi-Levrat S, Olavarria E, Iacobelli S, et al. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant. 2021;doi: 10.1038/s41409-021-01472-x.
Masouridi-Levrat, S., Olavarria, E., Iacobelli, S., Aljurf, M., Morozova, E., Niittyvuopio, R., Sengeloev, H., Reményi, P., Helbig, G., Browne, P., Ganser, A., Nagler, A., Snowden, J. A., Robin, M., Passweg, J., Van Gorkom, G., Wallet, H. L., Hoek, J., Blok, H. J., De Witte, T., Kroeger, N., Hayden, P., Chalandon, Y., & Agha, I. Y. (2021). Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone marrow transplantation, . https://doi.org/10.1038/s41409-021-01472-x
Masouridi-Levrat, Stavroula, et al. "Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT." Bone marrow transplantation vol. (2021). doi: https://doi.org/10.1038/s41409-021-01472-x
Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P, Ganser A, Nagler A, Snowden JA, Robin M, Passweg J, Van Gorkom G, Wallet HL, Hoek J, Blok HJ, De Witte T, Kroeger N, Hayden P, Chalandon Y, Agha IY. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant. 2021 Oct 01; doi: 10.1038/s41409-021-01472-x. Epub 2021 Oct 01. PMID: 34599284.
Copy Download .nbib Format: NLM
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.

Bone marrow transplantation

Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P, Ganser A, Nagler A, Snowden JA, Robin M, Passweg J, Van Gorkom G, Wallet HL, Hoek J, Blok HJ, De Witte T, Kroeger N, Hayden P, Chalandon Y, Agha IY.
PMID: 34599284
Bone Marrow Transplant. 2022 Jan;57(1):23-30. doi: 10.1038/s41409-021-01472-x. Epub 2021 Oct 01.

Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibitors (TKIs). While imatinib seems to have no adverse impact on outcomes after transplant, little is...

Cite
Masouridi-Levrat S, Olavarria E, Iacobelli S, et al. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant. 2021;57(1):23-30doi: 10.1038/s41409-021-01472-x.
Masouridi-Levrat, S., Olavarria, E., Iacobelli, S., Aljurf, M., Morozova, E., Niittyvuopio, R., Sengeloev, H., Reményi, P., Helbig, G., Browne, P., Ganser, A., Nagler, A., Snowden, J. A., Robin, M., Passweg, J., Van Gorkom, G., Wallet, H. L., Hoek, J., Blok, H. J., De Witte, T., Kroeger, N., Hayden, P., Chalandon, Y., & Agha, I. Y. (2022). Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone marrow transplantation, 57(1), 23-30. https://doi.org/10.1038/s41409-021-01472-x
Masouridi-Levrat, Stavroula, et al. "Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT." Bone marrow transplantation vol. 57,1 (2022): 23-30. doi: https://doi.org/10.1038/s41409-021-01472-x
Masouridi-Levrat S, Olavarria E, Iacobelli S, Aljurf M, Morozova E, Niittyvuopio R, Sengeloev H, Reményi P, Helbig G, Browne P, Ganser A, Nagler A, Snowden JA, Robin M, Passweg J, Van Gorkom G, Wallet HL, Hoek J, Blok HJ, De Witte T, Kroeger N, Hayden P, Chalandon Y, Agha IY. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT. Bone Marrow Transplant. 2022 Jan;57(1):23-30. doi: 10.1038/s41409-021-01472-x. Epub 2021 Oct 01. PMID: 34599284.
Copy Download .nbib Format: NLM
Predation risk increases in estuarine bivalves stressed by low salinity.

Marine biology

Domínguez R, Vázquez E, Smallegange IM, Woodin SA, Wethey DS, Peteiro LG, Olabarria C.
PMID: 34720192
Mar Biol. 2021;168(8):132. doi: 10.1007/s00227-021-03942-8. Epub 2021 Jul 24.

Salinity drops in estuaries after heavy rains are expected to increase in frequency and intensity over the next decades, with physiological and ecological consequences for the inhabitant organisms. It was investigated whether low salinity stress increases predation risk on...

Cite
Domínguez R, Vázquez E, Smallegange IM, et al. Predation risk increases in estuarine bivalves stressed by low salinity. Mar Biol. 2021;168(8):132doi: 10.1007/s00227-021-03942-8.
Domínguez, R., Vázquez, E., Smallegange, I. M., Woodin, S. A., Wethey, D. S., Peteiro, L. G., & Olabarria, C. (2021). Predation risk increases in estuarine bivalves stressed by low salinity. Marine biology, 168(8), 132. https://doi.org/10.1007/s00227-021-03942-8
Domínguez, Rula, et al. "Predation risk increases in estuarine bivalves stressed by low salinity." Marine biology vol. 168,8 (2021): 132. doi: https://doi.org/10.1007/s00227-021-03942-8
Domínguez R, Vázquez E, Smallegange IM, Woodin SA, Wethey DS, Peteiro LG, Olabarria C. Predation risk increases in estuarine bivalves stressed by low salinity. Mar Biol. 2021;168(8):132. doi: 10.1007/s00227-021-03942-8. Epub 2021 Jul 24. PMID: 34720192; PMCID: PMC8550793.
Copy Download .nbib Format: NLM
Correction: Postsurgical bile duct disruption: Digital single-operator cholangioscopy-assisted recanalization.

Endoscopy

González-Olivares CG, Foruny JR, Olavarría A, González Martín JÁ, López-Durán S, Vázquez-Sequeiros E, Albillos A.
PMID: 33971675
Endoscopy. 2021 Jul;53(7):C9. doi: 10.1055/a-1491-4311. Epub 2021 May 10.

No abstract available.

Cite
González-Olivares CG, Foruny JR, Olavarría A, et al. Correction: Postsurgical bile duct disruption: Digital single-operator cholangioscopy-assisted recanalization. Endoscopy. 2021;53(7):C9doi: 10.1055/a-1491-4311.
González-Olivares, C. G., Foruny, J. R., Olavarría, A., González Martín, J. �. �., López-Durán, S., Vázquez-Sequeiros, E., & Albillos, A. (2021). Correction: Postsurgical bile duct disruption: Digital single-operator cholangioscopy-assisted recanalization. Endoscopy, 53(7), C9. https://doi.org/10.1055/a-1491-4311
González-Olivares, Carolina G, et al. "Correction: Postsurgical bile duct disruption: Digital single-operator cholangioscopy-assisted recanalization." Endoscopy vol. 53,7 (2021): C9. doi: https://doi.org/10.1055/a-1491-4311
González-Olivares CG, Foruny JR, Olavarría A, González Martín JÁ, López-Durán S, Vázquez-Sequeiros E, Albillos A. Correction: Postsurgical bile duct disruption: Digital single-operator cholangioscopy-assisted recanalization. Endoscopy. 2021 Jul;53(7):C9. doi: 10.1055/a-1491-4311. Epub 2021 May 10. PMID: 33971675.
Copy Download .nbib Format: NLM
Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?.

Molecular neurodegeneration

Olabarria M, Noristani HN, Verkhratsky A, Rodríguez JJ.
PMID: 21801442
Mol Neurodegener. 2011 Jul 30;6:55. doi: 10.1186/1750-1326-6-55.

Astrocytes are fundamental for brain homeostasis and the progression and outcome of many neuropathologies including Alzheimer's disease (AD). In the triple transgenic mouse model of AD (3xTg-AD) generalised hippocampal astroglia atrophy precedes a restricted and specific β-amyloid (Aβ) plaque-related...

Cite
Olabarria M, Noristani HN, Verkhratsky A, et al. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Mol Neurodegener. 2011;6:55doi: 10.1186/1750-1326-6-55.
Olabarria, M., Noristani, H. N., Verkhratsky, A., & Rodríguez, J. J. (2011). Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Molecular neurodegeneration, 655. https://doi.org/10.1186/1750-1326-6-55
Olabarria, Markel, et al. "Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?." Molecular neurodegeneration vol. 6 (2011): 55. doi: https://doi.org/10.1186/1750-1326-6-55
Olabarria M, Noristani HN, Verkhratsky A, Rodríguez JJ. Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer's disease mouse model: mechanism for deficient glutamatergic transmission?. Mol Neurodegener. 2011 Jul 30;6:55. doi: 10.1186/1750-1326-6-55. PMID: 21801442; PMCID: PMC3199854.
Copy Download .nbib Format: NLM
Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient.

Journal of clinical pharmacy and therapeutics

Feliu J, Del Pozo JL, Azanza JR, García-Muñoz R, Zabalza A, Gorosquieta A, Pérez-Equiza E, Olavarría E.
PMID: 26073924
J Clin Pharm Ther. 2015 Oct;40(5):601-603. doi: 10.1111/jcpt.12299. Epub 2015 Jun 13.

WHAT IS KNOWN AND OBJECTIVE: Invasive fungal infections are a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). This provides a clear rationale for antifungal prophylaxis in this population. A concern is the potential for...

Cite
Feliu J, Del Pozo JL, Azanza JR, et al. Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient. J Clin Pharm Ther. 2015;40(5):601-603doi: 10.1111/jcpt.12299.
Feliu, J., Del Pozo, J. L., Azanza, J. R., García-Muñoz, R., Zabalza, A., Gorosquieta, A., Pérez-Equiza, E., & Olavarría, E. (2015). Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient. Journal of clinical pharmacy and therapeutics, 40(5), 601-603. https://doi.org/10.1111/jcpt.12299
Feliu, J, et al. "Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient." Journal of clinical pharmacy and therapeutics vol. 40,5 (2015): 601-603. doi: https://doi.org/10.1111/jcpt.12299
Feliu J, Del Pozo JL, Azanza JR, García-Muñoz R, Zabalza A, Gorosquieta A, Pérez-Equiza E, Olavarría E. Antifungal prophylaxis with anidulafungin to minimize drug interactions with an antiepileptic treatment in a hematopoietic stem cell transplant recipient. J Clin Pharm Ther. 2015 Oct;40(5):601-603. doi: 10.1111/jcpt.12299. Epub 2015 Jun 13. PMID: 26073924.
Copy Download .nbib Format: NLM
Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review.

Therapeutic advances in hematology

Zabalza A, Gorosquieta A, Equiza EP, Olavarria E.
PMID: 23730499
Ther Adv Hematol. 2013 Jun;4(3):217-30. doi: 10.1177/2040620713481796.

Invasive fungal infections (IFIs) have become high prevalence in patients with hematologic malignancies. Drug-based strategies for IFIs include various approaches such as prophylactic, empiric, preemptive, and directed treatment. Prophylaxis is an attractive strategy in high-risk patients, given the lack...

Cite
Zabalza A, Gorosquieta A, Equiza EP, et al. Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review. Ther Adv Hematol. 2013;4(3):217-30doi: 10.1177/2040620713481796.
Zabalza, A., Gorosquieta, A., Equiza, E. P., & Olavarria, E. (2013). Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review. Therapeutic advances in hematology, 4(3), 217-30. https://doi.org/10.1177/2040620713481796
Zabalza, Amaya, et al. "Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review." Therapeutic advances in hematology vol. 4,3 (2013): 217-30. doi: https://doi.org/10.1177/2040620713481796
Zabalza A, Gorosquieta A, Equiza EP, Olavarria E. Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review. Ther Adv Hematol. 2013 Jun;4(3):217-30. doi: 10.1177/2040620713481796. PMID: 23730499; PMCID: PMC3666449.
Copy Download .nbib Format: NLM
Responses to salinity stress in bivalves: Evidence of ontogenetic changes in energetic physiology on Cerastoderma edule.

Scientific reports

Peteiro LG, Woodin SA, Wethey DS, Costas-Costas D, Martínez-Casal A, Olabarria C, Vázquez E.
PMID: 29844535
Sci Rep. 2018 May 29;8(1):8329. doi: 10.1038/s41598-018-26706-9.

Estuarine bivalves are especially susceptible to salinity fluctuations. Stage-specific sensibilities may influence the structure and spatial distribution of the populations. Here we investigate differences on the energetic strategy of thread drifters (3-4 mm) and sedentary settlers (9-10 mm) of...

Cite
Peteiro LG, Woodin SA, Wethey DS, et al. Responses to salinity stress in bivalves: Evidence of ontogenetic changes in energetic physiology on Cerastoderma edule. Sci Rep. 2018;8(1):8329doi: 10.1038/s41598-018-26706-9.
Peteiro, L. G., Woodin, S. A., Wethey, D. S., Costas-Costas, D., Martínez-Casal, A., Olabarria, C., & Vázquez, E. (2018). Responses to salinity stress in bivalves: Evidence of ontogenetic changes in energetic physiology on Cerastoderma edule. Scientific reports, 8(1), 8329. https://doi.org/10.1038/s41598-018-26706-9
Peteiro, Laura G, et al. "Responses to salinity stress in bivalves: Evidence of ontogenetic changes in energetic physiology on Cerastoderma edule." Scientific reports vol. 8,1 (2018): 8329. doi: https://doi.org/10.1038/s41598-018-26706-9
Peteiro LG, Woodin SA, Wethey DS, Costas-Costas D, Martínez-Casal A, Olabarria C, Vázquez E. Responses to salinity stress in bivalves: Evidence of ontogenetic changes in energetic physiology on Cerastoderma edule. Sci Rep. 2018 May 29;8(1):8329. doi: 10.1038/s41598-018-26706-9. PMID: 29844535; PMCID: PMC5974369.
Copy Download .nbib Format: NLM
Appropriate experimental design to evaluate preferences for microhabitat: an example of preferences by species of microgastropods.

Oecologia

Olabarria C, Underwood A, Chapman M.
PMID: 28547347
Oecologia. 2002 Jul;132(2):159-166. doi: 10.1007/s00442-002-0940-6. Epub 2002 Jul 01.

The intertidal microgastropods Eatoniella atropurpurea, Amphithalamus incidata and Eatonina rubrilabiata are principally found at mid- to low-shore levels in coralline turf and in patches of sediment close to algal turf on rocky shores. All three species are more abundant...

Cite
Olabarria C, Underwood A, Chapman M. Appropriate experimental design to evaluate preferences for microhabitat: an example of preferences by species of microgastropods. Oecologia. 2002;132(2):159-166doi: 10.1007/s00442-002-0940-6.
Olabarria, C., Underwood, A., & Chapman, M. (2002). Appropriate experimental design to evaluate preferences for microhabitat: an example of preferences by species of microgastropods. Oecologia, 132(2), 159-166. https://doi.org/10.1007/s00442-002-0940-6
Olabarria, C, et al. "Appropriate experimental design to evaluate preferences for microhabitat: an example of preferences by species of microgastropods." Oecologia vol. 132,2 (2002): 159-166. doi: https://doi.org/10.1007/s00442-002-0940-6
Olabarria C, Underwood A, Chapman M. Appropriate experimental design to evaluate preferences for microhabitat: an example of preferences by species of microgastropods. Oecologia. 2002 Jul;132(2):159-166. doi: 10.1007/s00442-002-0940-6. Epub 2002 Jul 01. PMID: 28547347.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries